Why Nestle Is Eyeing Merck's Consumer Health Unit

The video discusses Nestle's strategic shift towards healthcare under CEO Mark Schneider, highlighting their acquisition of Atrium Innovation. It compares Nestle's asset sales with Pfizer's, noting the higher valuation of Pfizer's assets. Merck's future plans post-sale are explored, along with industry trends and potential deals emerging from a healthcare conference in San Francisco.

What are some potential uses for the money that Merck might receive from their sale?

What trends in the healthcare industry were mentioned regarding potential future deals?